Regulated Information

To guarantee transparency and sustainability, we abide by a strict set of rules and regulations.

Use the links below to review investor information. If more information is needed, please contact us.

2024

No regulated information available

September 05, 2024

2024 Half-Year Financial Report

Download

September 05, 2024

Notice of publication of the 2024 Half-Year Financial Report

Download

March 28, 2024

Release of the Universal Registration Document including the Annual Financial Report as of December 31, 2023

Download

January 06, 2025

December 2024 - Declaration about number of shares issued and number of voting rights

Download

December 05, 2024

November 2024 - Declaration about number of shares issued and number of voting rights

Download

November 06, 2024

October 2024 - Declaration about number of shares issued and number of voting rights

Download

October 08, 2024

September 2024 - Declaration about number of shares issued and number of voting rights

Download

September 10, 2024

August 2024 - Declaration about number of shares issued and number of voting rights

Download

August 06, 2024

July 2024 - Declaration about number of shares issued and number of voting rights

Download

July 05, 2024

June 2024 - Declaration about number of shares issued and number of voting rights

Download

June 05, 2024

May 2024 - Declaration about number of shares issued and number of voting rights

Download

May 06, 2024

April 2024 - Declaration about number of shares issued and number of voting rights

Download

April 05, 2024

March 2024 - Declaration about number of shares issued and number of voting rights

Download

March 04, 2024

February 2024 - Declaration about number of shares issued and number of voting rights

Download

February 02, 2024

January 2024 - Declaration about number of shares issued and number of voting rights

Download

December 06, 2024

BIOFIRE FILMARRAY Tropical Fever Panel

Download

November 11, 2024

Canada's First Center of Excellence in the Fight Against Antimicrobial Resistance

Download

October 29, 2024

Third-Quarter 2024 Business Review

Download

October 14, 2024

VIDAS Vitamin B12 TOTAL CE-Marking - Press Release

Download

September 19, 2024

Innovation Center Philadelphia Opening - Press Release

Download

September 04, 2024

First-Half 2024 Results - bioMérieux Press Release

Download

June 25, 2024

BIOFIRE® SPOTFIRE® R/ST Panel Mini FDA Clearance - Press Release

Download

June 21, 2024

VITEK REVEAL FDA Clearance - Press Release

Download

May 24, 2024

VIDAS TBI FDA Clearance - Press Release

Download

May 23, 2024

Malawi MoH, bioMérieux and Pfizer AMR Collaboration - Press Release

Download

April 09, 2024

bioMérieux presents its new 5-year strategic plan

Download

April 09, 2024

First-Quarter 2024 Business Review - Press Release

Download

April 03, 2024

Trusted Third Party Model by bioMérieux and Mérieux NutriSciences - Press Release

Download

March 28, 2024

FDA clearance and CLIA-waiver for the BIOFIRE® SPOTFIRE® R/ST Panel

Download

March 14, 2024

bioMérieux – 2023 Financial Results - Press Release

Download

January 12, 2024

Nominations Executive Committee - Press Release

Download

January 08, 2024

bioMérieux acquires LUMED - Press Release

Download

March 25, 2024

AG 2024 - Notice preparatory documents - General shareholders meeting.pdf

Download

No regulated information available

May 23, 2024

AG 2024 - Description of the shares repurchase program

Download

No regulated information available

2023

September 04, 2023

2023 HY Financial Report

Download

September 04, 2023

Notice of publication of the 2023 HY Financial Report

Download

March 22, 2023

Release of the Universal Registration Document including the Annual Financial Report as of December 31, 2022

Download

No regulated information available

January 05, 2024

December 2023 - Declaration about number of shares issued and number of voting rights

Download

December 07, 2023

November 2023 - Declaration about number of shares issued and number of voting rights

Download

November 09, 2023

October 2023 - Declaration about number of shares issued and number of voting rights

Download

October 05, 2023

September 2023 - Declaration about number of shares issued and number of voting rights

Download

September 05, 2023

August 2023 - Declaration about number of shares issued and number of voting rights

Download

August 04, 2023

July 2023 - Declaration about number of voting rights and shares

Download

July 04, 2023

June 2023 - Declaration about number of shares issued and number of voting rights

Download

June 05, 2023

May 2023 - Declaration about number of shares issued and number of voting rights

Download

May 04, 2023

April 2023 - Declaration about number of shares issued and number of voting rights

Download

April 05, 2023

March 2023 - Declaration about number of shares issued and number of voting rights

Download

March 07, 2023

February 2023 - Declaration about number of shares issued and number of voting rights

Download

February 03, 2023

January 2023 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

November 28, 2023

Launch of a new industrial chair, in Lyon on viral respiratory infections - Press Release

Download

October 25, 2023

Third-Quarter 2023 Business Review - Press Release

Download

October 19, 2023

bioMérieux Strategic Investment In Oxford Nanopore - Press Release

Download

October 03, 2023

CE-marking of VIDAS TBI (GFAP, UCH-L1) - Press Release

Download

September 21, 2023

bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel - Press Release

Download

August 31, 2023

First-Half 2023 Results - Press Release

Download

June 27, 2023

Jennifer Zinn appointed Executive Vice President Clinical Operations - Press Release

Download

June 13, 2023

bioMérieux_PR_Governance_20230614.pdf

Download

May 09, 2023

bioMérieux receives US FDA CLIA-waiver for the BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini

Download

April 26, 2023

First-Quarter 2023 Business Review - Press Release

Download

April 14, 2023

Oxford Nanopore and bioMérieux to enter into a strategic partnership agreement - Press Release

Download

April 13, 2023

BIOFIRE SPOTFIRE R Panel Mini FDA-cleared - Press Release

Download

April 06, 2023

VITEK REVEAL FDA Submission - Press Release

Download

April 03, 2023

BIOFIRE FIREWORKS launch - Press Release

Download

March 09, 2023

BioFire Defense partners with BARDA - Press Release

Download

March 07, 2023

bioMérieux - 2022 Financial Results - Press Release

Download

February 09, 2023

BIOFIRE SPOTFIRE FDA CLEARANCE

Download

January 24, 2023

Maestria Launch - Press Release

Download

No regulated information available

January 04, 2024

Biannual report on bioMérieux's liquidity agreement as of December 30, 2023

Download

November 20, 2023

Biannual report on bioMérieux's liquidity agreement as of June 30, 2023

Download

September 21, 2023

Disclosure of trading in own shares on september 18th

Download

September 21, 2023

Disclosure of trading in own shares on june 23d

Download

May 23, 2023

AG 2023 - Description of shares repurchase program

Download

No regulated information available

2022

September 01, 2022

Notice of publication of the 2022 HY Financial Report

Download

August 31, 2022

2022 HY Financial Report

Download

March 21, 2022

Release of 2021 URD

Download

No regulated information available

January 04, 2023

December 2022 - Declaration about number of shares issued and number of voting rights

Download

December 05, 2022

November 2022 - Declaration about number of shares issued and number of voting rights

Download

November 07, 2022

October 2022 - Declaration about number of shares issued and number of voting rights

Download

October 04, 2022

September 2022 - Declaration about number of shares issued and number of voting rights

Download

September 02, 2022

August 2022 - Declaration about number of shares issued and number of voting rights

Download

August 02, 2022

July 2022 – Declaration about number of shares issued and number of voting rights

Download

July 04, 2022

June 2022 - Declaration about number of shares issued and number of voting rights

Download

June 03, 2022

May 2022 - Declaration about number of shares issued and number of voting rights

Download

May 03, 2022

April 2022 - Declaration about number of shares issued and number of voting rights

Download

April 04, 2022

March 2022 – Declaration about number of shares issued and number of voting rights

Download

March 07, 2022

February 2022 - Declaration about number of shares issued and number of voting rights

Download

February 03, 2022

January 2022 - Declaration about number of shares issued and number of voting rights

Download

January 10, 2022

December 2021 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

December 19, 2022

VIDAS KUBE CE-Marking - Press Release

Download

December 14, 2022

bioMérieux - Increased outlook for full-year 2022 and 2023 guidance preview

Download

October 26, 2022

Third-Quarter 2022 Business Review - Press Release

Download

September 23, 2022

Sepsis Bundles Survey - Press Release - UK

Download

September 20, 2022

Sepsis Bundles Survey - Press Release

Download

August 30, 2022

First-Half 2022 Results

Download

August 22, 2022

The SPECIFIC REVEAL® Rapid AST System has received Breakthrough Device Designation from the FDA

Download

July 26, 2022

20220728 _PR_VIDAS_NEPHROCHECK_FDA_Clearance_EN.pdf

Download

July 01, 2022

Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance

Download

June 30, 2022

bioMérieux launches 3P® ENTERPRISE

Download

May 19, 2022

Closing of the acquisition of Specific Diagnostics

Download

May 11, 2022

bioMérieux announces the CE marking of VIDAS® tests for Chikungunya virus diagnosis

Download

May 02, 2022

bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection (JI) Panel

Download

April 12, 2022

bioMérieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solution

Download

April 11, 2022

bioMérieux – First-Quarter 2022 Business Review

Download

March 17, 2022

bioMérieux receives FDA 510(k) clearance for its VITEK® MS PRIME new MALDI-TOF mass spectrometry identification system

Download

March 01, 2022

bioMérieux – 2021 Financial Results

Download

February 14, 2022

MYACUTECASE™, a free mobile application by bioMérieux to support clinicians in decision-making and monitoring of patients using emergency and critical care diagnostics

Download

January 03, 2022

French multidisciplinary consortium ARPEGE awarded public funding of close to €9 million to fight antibiotic resistance

Download

April 12, 2022

AG 2022 - Notice of information relating to preparatory documents for the Ordinary and Extraordinary Shareholders' Meeting of May 23, 2022

Download

No regulated information available

2011

October 20, 2011

bioMérieux - Business Review for the nine months ended September 30, 2011

Download

September 06, 2011

Rapport financier semestriel relatif au premier semestre clos le 30 juin 2011

Download

July 19, 2011

bioMérieux - First-Half 2011 Business Review

Download

June 30, 2011

Registration Document and Annual Financial Report 2010

Download

April 21, 2011

bioMérieux - First-Quarter 2011 Business Review

Download

January 19, 2011

bioMérieux – 2010 Business Review

Download

No regulated information available

December 05, 2011

November 2011 - Declaration about number of shares issued and number of voting rights

Download

November 04, 2011

October 2011 - Declaration about number of shares issued and number of voting rights

Download

October 04, 2011

September 2011 - Declaration about number of shares issued and number of voting rights

Download

September 02, 2011

August 2011 - Declaration about number of shares issued and number of voting rights

Download

August 29, 2011

July 2011 - Declaration about number of shares issued and number of voting rights

Download

July 04, 2011

June 2011 - Declaration about number of shares issued and number of voting rights

Download

June 10, 2011

May 2011 - Declaration about number of shares issued and number of voting rights

Download

May 03, 2011

April 2011 - Declaration about number of shares issued and number of voting rights

Download

April 04, 2011

March 2011 - Declaration about number of shares issued and number of voting rights

Download

March 02, 2011

February 2011 - Declaration about number of shares issued and number of voting rights

Download

January 31, 2011

January 2011 - Declaration about number of shares issued and number of voting rights

Download

January 04, 2011

December 2010 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

December 07, 2011

bioMérieux - Information on 2011 sales objective

Download

November 17, 2011

bioMérieux Initiative to Support European Antibiotic Awareness Day

Download

October 20, 2011

bioMérieux Business Review for the nine months ended September 30, 2011

Download

September 27, 2011

Mise en œuvre du retrait obligatoire visant les actions AES Chemunex

Download

September 06, 2011

bioMérieux - First-Half Results at June 30, 2011

Download

July 27, 2011

New Study Reports: CancerTYPE ID Expands Tumor Type Coverage and Demonstrates Clinical Utility - CancerTYPE ID is Now a Covered Benefit for Medicare Part B Patients

Download

July 27, 2011

New Study Reports: CancerTYPE ID Expands Tumor Type Coverage and Demonstrates Clinical Utility - CancerTYPE ID is Now a Covered Benefit for Medicare Part B Patients

Download

July 19, 2011

bioMérieux - First-Half 2011 Business Review

Download

July 19, 2011

bioMérieux Expands its Infectious Disease Offering with Acquisition of ARGENE, Specialized in Molecular Diagnostics for Immunocompromised Patients

Download

June 30, 2011

World HAI Forum: Global Call to Action to Fight Antibiotic Resistance

Download

June 22, 2011

bioMérieux Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety

Download

May 24, 2011

bioMérieux Receives FDA Clearance for NucliSENS EasyQ® MRSA, Automated, Rapid Molecular Screening Test

Download

May 19, 2011

bioMérieux Becomes the World Leader in Food Testing with AES Laboratoire Acquisition

Download

May 04, 2011

bioMérieux and Labor Berlin (Charité Vivantes GmbH) to Establish Center of Excellence in Laboratory Diagnostics

Download

April 21, 2011

bioMérieux - First-Quarter 2011 Business Review

Download

April 06, 2011

bioMérieux Achieves 100th PREVI™ Isola Milestone, Installing its Automated Plate Streaker at Grady Health System

Download

March 08, 2011

bioMérieux - 2010 Financial Results

Download

January 27, 2011

Ipsen and bioMérieux enter into a broad partnership in personalized medicine

Download

January 27, 2011

Philips and bioMérieux announce milestone in the development of innovative handheld diagnostic solutions for rapid point-of-care testing

Download

January 04, 2011

bioMérieux Expands Customer Services Offer, Appointing James P. Whelan as Executive Vice President, Commercial Services

Download

No regulated information available

2021

September 02, 2021

Notice of Publication of the 2021 HY Financial Report

Download

September 01, 2021

2021 HY Financial Report

Download

August 31, 2021

bioMérieux - 2021 HY Financial Results

Download

No regulated information available

December 08, 2021

November 2021 - Declaration about number of shares issued and number of voting rights

Download

November 05, 2021

October 2021 - Declaration about number of shares issued and number of voting rights

Download

October 08, 2021

January 2021 - Declaration about number of shares issued and number of voting rights

Download

September 06, 2021

September 2021 - Declaration about number of shares issued and number of voting rights

Download

August 12, 2021

August 2021 - Declaration about number of shares issued and number of voting rights

Download

July 07, 2021

July 2021 - Declaration about number of shares issued and number of voting rights

Download

June 10, 2021

June 2021 - Declaration about number of shares issued and number of voting rights

Download

May 05, 2021

May 2021 - Declaration about number of shares issued and number of voting rights

Download

April 07, 2021

April 2021 - Declaration about number of shares issued and number of voting rights

Download

March 04, 2021

March 2021 - Declaration about number of shares issued and number of voting rights

Download

February 05, 2021

December 2020 - Declaration about number of shares issued and number of voting rights

Download

January 08, 2021

February 2021 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

December 10, 2021

bioMérieux – Increased outlook for full-year 2021

Download

December 09, 2021

Corporate Social Responsibility: bioMérieux recently received a series of official recognitions from independent third parties

Download

December 01, 2021

bioMérieux molecular tests efficiently detect SARS-CoV-2 Omicron variant

Download

October 20, 2021

Baxter and bioMérieux announce CE mark for NEPHROCLEAR™ CCL14 test to predict persistent severe acute kidney injury

Download

October 20, 2021

bioMérieux – Third-Quarter 2021 Business Review

Download

September 09, 2021

A survey in 5 European countries about sepsis demonstrates the lack of awareness and an expectation for faster diagnostic capabilities

Download

August 31, 2021

bioMérieux – First-Half 2021 Results

Download

June 29, 2021

In the fight against Antimicrobial Resistance, bioMérieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL® Rapid AST system in Europe

Download

June 28, 2021

bioMérieux launches EPISEQ® SARS-COV-2, a cloud-based software application for the epidemiological surveillance of SARS-CoV-2 variants

Download

May 07, 2021

bioMérieux announces the CE marking of the new generation semi-quantitative VIDAS® SARS-COV-2 IgG II serology test.

Download

April 27, 2021

bioMérieux announces CE-marking of the new MALDI-TOF mass spectrometry identification system: VITEK® MS PRIME

Download

April 26, 2021

bioMérieux – First-Quarter 2021 Business Review

Download

April 06, 2021

bioMérieux announces the CE marking of 3 dengue immunoassays on VIDAS®

Download

March 23, 2021

bioMérieux announces the CE marking of TB IGRA® test on VIDAS®

Download

March 17, 2021

BIOFIRE® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 obtains De Novo FDA Authorization

Download

March 12, 2021

The Biotech Digital Campus joins forces with biotechnology schools and training organizations to develop the talents of tomorrow

Download

February 23, 2021

bioMérieux – 2020 Financial Results

Download

February 02, 2021

bioMérieux announces the CE marking of NEPHROCHECK® test on VIDAS®

Download

April 09, 2021

Notice of information related to preparatory documents for the Ordinary and Extraordinary Shareholders’ Meeting of May 20, 2021

Download

No regulated information available

2020

September 10, 2020

Interim Financial Report 2020

Download

September 02, 2020

Notice of Publication of the 2020 HY Financial Report

Download

September 01, 2020

First-Half 2020 Results

Download

July 08, 2020

Second-Quarter 2020 Business Performance Preannouncement

Download

February 27, 2020

bioMérieux – 2019 Financial Results

Download

December 03, 2020

declaration_capital_et_droits_de_vote_au_30_11_2020_0.pdf

Download

November 04, 2020

declaration_capital_et_droits_de_vote_au_31_10_2020_0.pdf

Download

October 05, 2020

declaration_capital_et_droits_de_vote_au_30_09_2020_0.pdf

Download

September 03, 2020

declaration_capital_et_droits_de_vote_au_31_08_2020.pdf

Download

August 06, 2020

declaration_capital_et_droits_de_vote_au_31_07_2020.pdf

Download

July 08, 2020

declaration_capital_et_droits_de_vote_au_30_06_2020.pdf

Download

June 04, 2020

declaration_capital_et_droits_de_vote_au_31_05_2020.pdf

Download

May 07, 2020

declaration_capital_et_droits_de_vote_au_30_04_2020_0.pdf

Download

April 06, 2020

declaration_capital_et_droits_de_vote_au_31_03_2020.pdf

Download

March 05, 2020

declaration_capital_et_droits_de_vote_au_29_02_2020.pdf

Download

February 12, 2020

declaration_capital_et_droits_de_vote_au_30_01_2020.pdf

Download

January 13, 2020

declaration_capital_et_droits_de_vote_au_31_12_2019.pdf

Download

No regulated information available

December 03, 2020

November 2020 - Declaration about number of shares issued and number of voting rights

Download

November 04, 2020

October 2020 - Declaration about number of shares issued and number of voting rights

Download

October 05, 2020

September 2020 - Declaration about number of shares issued and number of voting rights

Download

September 03, 2020

August 2020 - Declaration about number of shares issued and number of voting rights

Download

August 06, 2020

July 2020 - Declaration about number of shares issued and number of voting rights

Download

July 08, 2020

June 2020 - Declaration about number of shares issued and number of voting rights

Download

June 04, 2020

May 2020 - Declaration about number of shares issued and number of voting rights

Download

May 07, 2020

April 2020 - Declaration about number of shares issued and number of voting rights

Download

April 06, 2020

March 2020 - Declaration about number of shares issued and number of voting rights

Download

March 05, 2020

February 2020 - Declaration about number of shares issued and number of voting rights

Download

February 12, 2020

January 2020 - Declaration about number of shares issued and number of voting rights

Download

January 13, 2020

December 2019 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

December 15, 2020

bioMérieux announces the CE marking of its molecular biology ARGENE® test for the simultaneous detection of SARS-CoV-2, influenza viruses A and B, and RSV and hMPV viruses

Download

December 14, 2020

Increased outlook for full-year 2020

Download

December 14, 2020

The French bioproduction sector announces the creation of Campus Biotech Digital, a platform unique in the world for bioproduction training

Download

December 02, 2020

BIOASTER, Université de Technologie de Compiègne, Hospices Civils de Lyon and bioMérieux formalize strategic collaboration to conduct Next Generation Sequencing technology evaluation in microbiology

Download

November 16, 2020

bioMérieux announces the expansion of the CE marking of its molecular biology ARGENE® SARS-CoV-2 diagnostic test to include saliva specimens.

Download

October 21, 2020

bioMérieux – Third-Quarter 2020 Business Review

Download

October 09, 2020

AMSP partners with bioMérieux to facilitate supply of high-quality COVID-19 diagnostics

Download

July 15, 2020

Launch of BIOFIRE® MYCOPLASMA test for mycoplasma detection in biopharmaceutical products

Download

July 14, 2020

BIOFIRE® Respiratory Panel 2.1 plus with SARS-CoV-2 is CE marked

Download

June 29, 2020

bioMérieux issues a €200 million Euro PP bond

Download

May 20, 2020

CE marking of bioMérieux serology tests for SARS-CoV-2 on VIDAS®

Download

May 19, 2020

Information concerning 2019 dividend and the bioMérieux General Shareholders’ Meeting

Download

May 05, 2020

bioMérieux serology tests for SARS-CoV-2 on VIDAS® undergo validation preceding imminent launch

Download

May 03, 2020

BIOFIRE® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 obtains FDA Emergency Use Authorization

Download

April 15, 2020

First-Quarter 2020 Business Review

Download

March 23, 2020

bioMérieux receives Emergency Use Authorization for BIOFIRE COVID-19 test

Download

March 10, 2020

First of 3 diagnostic tests for SARS-CoV-2 coronavirus available from bioMérieux

Download

January 13, 2020

bioMérieux submits enhanced BIOFIRE BCID2 Panel for FDA clearance

Download

May 22, 2020

Notice of information related to preparatory documents for the Ordinary and Extraordinary Shareholders’ Meeting of June 30, 2020

Download

No regulated information available

2019

October 21, 2019

bioMérieux –Third-Quarter 2019 Business Review

Download

September 11, 2019

Interim financial report 2018

Download

September 05, 2019

Avis de mise à disposition du rapport financier semestriel 2019

Download

September 03, 2019

bioMérieux – First-Half 2019 Results

Download

April 23, 2019

bioMérieux – First-Quarter 2019 Business Review

Download

No regulated information available

December 06, 2019

November 2019 - Declaration about number of shares issued and number of voting rights

Download

November 08, 2019

October 2019 - Declaration about number of shares issued and number of voting rights

Download

October 07, 2019

September 2019 - Declaration about number of shares issued and number of voting rights

Download

September 05, 2019

August 2019 - Declaration about number of shares issued and number of voting rights

Download

August 07, 2019

July 2019 - Declaration about number of shares issued and number of voting rights

Download

July 04, 2019

June 2019 - Declaration about number of shares issued and number of voting rights

Download

June 11, 2019

May 2019 - Declaration about number of shares issued and number of voting rights

Download

May 06, 2019

April 2019 - Declaration about number of shares issued and number of voting rights

Download

April 05, 2019

March 2019 - Declaration about number of shares issued and number of voting

Download

March 06, 2019

February 2019 - Declaration about number of shares issued and number of voting rights

Download

February 07, 2019

January 2019 - Declaration about number of shares issued and number of voting rights

Download

January 07, 2019

December 2018 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

December 17, 2019

bioMérieux and the Fleming Fund: working together to strengthen diagnostic capacity and tackle antimicrobial resistance in low- and middle-income countries

Download

October 21, 2019

Third-Quarter 2019 Business Review

Download

September 04, 2019

First-Half 2019 Results - September 4, 2019

Download

June 05, 2019

bioMérieux increases its holding in Hybiome from 54% to 67%

Download

May 12, 2019

NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in the ERAS "Guidelines for Perioperative Care in Cardiac Surgery”

Download

April 23, 2019

bioMérieux – First-Quarter 2019 Business Review

Download

April 15, 2019

(bioMérieux Communiqué de mise à disposition du document de référence incluant le rapport financier annuel 2016)

Download

April 14, 2019

“Global-PPS”, a survey of antibiotic use and bacterial resistance in hospitals worldwide, tops the 200,000 patients

Download

March 29, 2019

University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics

Download

March 18, 2019

Baxter and bioMérieux announce collaboration to improve identification and treatment of acute kidney injury

Download

February 27, 2019

bioMérieux – 2018 Financial Results

Download

February 06, 2019

bioMérieux acquires Invisible Sentinel, a US-based company specialized in food and beverage molecular testing

Download

January 11, 2019

Follow up of the market making agreement at Dec 31, 2018

Download

No regulated information available

2018

October 23, 2018

bioMérieux – Business review for the nine months ended September 30, 2018

Download

September 14, 2018

Interim financial report 2018

Download

September 05, 2018

Avis_mise_a_disposition_rapport_financier_semestriel_2018

Download

September 04, 2018

bioMérieux – First-Half 2018 Results

Download

April 18, 2018

bioMérieux – First-Quarter 2018 Business Review

Download

February 27, 2018

bioMérieux – 2017 Financial Results

Download

January 22, 2018

bioMérieux – Fourth-quarter 2017 Business Review

Download

No regulated information available

December 04, 2018

November 2018 - Declaration about number of shares issued and number of voting rights

Download

November 06, 2018

October 2018 - Declaration about number of shares issued and number of voting rights

Download

October 04, 2018

September 2018 - Declaration about number of shares issued and number of voting rights

Download

September 03, 2018

August 2018 - Declaration about number of shares issued and number of voting rights

Download

August 06, 2018

July 2018 - Declaration about number of shares issued and number of voting rights

Download

July 04, 2018

June 2018 - Declaration about number of shares issued and number of voting rights

Download

June 05, 2018

May 2018 - Declaration about number of shares issued and number of voting rights

Download

May 03, 2018

April 2018 - Declaration about number of shares issued and number of voting rights

Download

April 06, 2018

March 2018 - Declaration about number of shares issued and number of voting rights

Download

March 05, 2018

February 2018 - Declaration about number of shares issued and number of voting rights

Download

February 06, 2018

January 2018 - Declaration about number of shares issued and number of voting rights

Download

January 05, 2018

December 2017 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

November 12, 2018

bioMérieux launches the BIOFIRE® FILMARRAY® Pneumonia Panels with FDA clearance and CE Marking

Download

November 09, 2018

bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market

Download

September 05, 2018

First-Half 2018 Results - September 5, 2018

Download

July 17, 2018

bioMérieux – Second-Quarter 2018 Business Review

Download

July 06, 2018

Follow up of the market making agreement at Jun 30, 2018

Download

May 30, 2018

bioMérieux launches ENDOZYME® II GO, an innovative test for the detection of endotoxins in pharmaceutical microbiology control

Download

May 01, 2018

NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in Groundbreaking Consensus Statement of Best Practices to Enhance Recovery after Heart Surgery

Download

April 18, 2018

bioMérieux submits for FDA Clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel

Download

April 04, 2018

bioMérieux reinforces its offering of High Medical Value immunoassay biomarkers with the acquisition of Astute Medical

Download

February 28, 2018

FY 2017 Results - February 28, 2018

Download

January 08, 2018

Follow up of the market making agreement at Dec 31, 2017

Download

No regulated information available

2017

October 17, 2017

bioMérieux – Business review for the nine months ended September 30, 2017

Download

September 06, 2017

bioMérieux - Interim Financial Report 2017

Download

August 29, 2017

bioMérieux – First-Half 2017 Results

Download

July 20, 2017

bioMérieux - Second Quarter 2017 Business Review

Download

April 19, 2017

bioMérieux – First-Quarter 2017 Business Review

Download

January 18, 2017

bioMérieux - Fourth-Quarter 2016 Business Review

Download

No regulated information available

December 05, 2017

November 2017 - Declaration about number of shares issued and number of voting rights

Download

November 06, 2017

October 2017 - Declaration about number of shares issued and number of voting rights

Download

October 06, 2017

September 2017 - Declaration about number of shares issued and number of voting rights

Download

September 05, 2017

August 2017 - Declaration about number of shares issued and number of voting rights

Download

August 03, 2017

July 2017 - Declaration about number of shares issued and number of voting rights

Download

July 06, 2017

June 2017 - Declaration about number of shares issued and number of voting rights

Download

June 07, 2017

May 2017 - Declaration about number of shares issued and number of voting rights

Download

May 05, 2017

April 2017 - Declaration about number of shares issued and number of voting rights

Download

April 06, 2017

March 2017 - Declaration about number of shares issued and number of voting rights

Download

March 03, 2017

February 2017 - Declaration about number of shares issued and number of voting rights

Download

February 06, 2017

January 2017 - Declaration about number of shares issued and number of voting rights

Download

January 05, 2017

December 2016 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

January 22, 2018

biomerieux_pr_sales_q4_2017.pdf

Download

December 15, 2017

Alexandre Mérieux appointed Chairman and CEO of bioMérieux

Download

August 30, 2017

First-Half 2017 Results - August 30, 2017

Download

August 29, 2017

bioMérieux - Release concerning the Interim Financial Report 2017

Download

July 30, 2017

bioMérieux receives FDA clearance for expanded pathogen identification capability on VITEK® MS

Download

July 27, 2017

2010年6月1日

Download

July 20, 2017

biomerieux_pr_sales_q2_2017.pdf

Download

July 05, 2017

Follow up of the market making agreement at Jun 30, 2017

Download

May 31, 2017

pr_biomerieux_filmarray_rp2_fda_clearance_0.pdf

Download

April 19, 2017

pr_biomerieux_filmarray_rp2plus_ce_marking_2017_04_20.pdf

Download

April 19, 2017

biomerieux_pr_sales_q1_2017.pdf

Download

April 05, 2017

bioMérieux receives FDA 510(k) clearance for its BacT/ALERT® VIRTUO™ fully automated blood culture system

Download

March 14, 2017

bioMérieux - Release of Registration Document including Annual Financial Report 2016

Download

March 01, 2017

FY 2016 Results - March 1, 2017

Download

February 28, 2017

bioMérieux – 2016 Financial Results

Download

February 23, 2017

biomerieux_-_pr_pct_claim_expansion_antibiotic_management.pdf

Download

January 18, 2017

bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury

Download

January 09, 2017

Follow up of the market making agreement at Dec 31, 2016

Download

November 09, 2016

pr_biomerieux_-_emag_launch_20161110.pdf

Download

No regulated information available

2016

October 19, 2016

bioMérieux – Business Review for the nine months ended September 30, 2016

Download

September 05, 2016

Interim Financial Report 2016

Download

August 31, 2016

Interim Financial Report 2016

Download

August 30, 2016

bioMérieux – First-Half 2016 Results

Download

July 17, 2016

bioMérieux – Second-Quarter 2016 Business Review

Download

June 30, 2016

bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B•R•A•H•M•S PCT™ Test for Managing Sepsis Patients

Download

April 20, 2016

First-Quarter 2016 Business Review

Download

March 01, 2016

bioMérieux – 2015 Financial Results

Download

January 20, 2016

bioMérieux – Fourth-Quarter 2015 Business Review

Download

No regulated information available

November 04, 2016

October 2016 - Declaration about number of shares issued and number of voting rights

Download

October 07, 2016

September 2016 - Declaration about number of shares issued and number of voting rights

Download

September 07, 2016

August 2016 - Declaration about number of shares issued and number of voting rights

Download

August 05, 2016

July 2016 - Declaration about number of shares issued and number of voting rights

Download

July 08, 2016

Déclaration Capital et droits de vote au 30 06 2016

Download

June 07, 2016

May 2016 - Declaration about number of shares issued and number of voting rights

Download

May 04, 2016

April 2016 - Declaration about number of shares issued and number of voting rights

Download

April 05, 2016

March 2016 - Declaration about number of shares issued and number of voting rights

Download

March 04, 2016

February 2016 - Declaration about number of shares issued and number of voting rights

Download

February 04, 2016

Janvier 2016 - Declaration about number of shares issued and number of voting rights

Download

January 08, 2016

December 2015 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

November 09, 2016

bioMérieux launches eMAG®, a new generation automated system for the extraction of DNA and RNA

Download

November 07, 2016

Pierre Boulud appointed Corporate Vice President of the Asia Pacific region at bioMérieux

Download

October 19, 2016

bioMérieux – Business Review for the nine months ended September 30, 2016

Download

October 16, 2016

Lyme disease diagnostic tests

Download

October 10, 2016

FilmArray® Respiratory Panel EZ is CLIA waived by the FDA

Download

October 07, 2016

BIOASTER, bioMérieux, ESPCI, GSK, Hospices Civils de Lyon and Sanofi join forces against sepsis

Download

October 05, 2016

bioMérieux introduces EviSight™ Compact, a new automated diagnostic solution for microbial detection in pharmaceutical production

Download

August 31, 2016

First-Half 2016 Results - August 31, 2016

Download

August 30, 2016

bioMérieux – First-Half 2016 Results

Download

July 17, 2016

bioMérieux – Second-Quarter 2016 Business Review

Download

July 05, 2016

bioMérieux enlarges its pathogen identification capability on VITEK® MS

Download

June 30, 2016

bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B•R•A•H•M•S PCT™ Test for Managing Sepsis Patients with elevated risk of mortality

Download

May 31, 2016

bioMérieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1

Download

April 20, 2016

bioMérieux – First-Quarter 2016 Business Review

Download

April 08, 2016

bioMérieux and Antwerp University unveil the final results of the first Global Point Prevalence Survey1 of antibiotic use and resistance rates in hospitals

Download

April 07, 2016

FilmArray® Torch is now FDA cleared with all 4 existing FilmArray® Panels and the system gets CE marked

Download

March 21, 2016

bioMérieux and COPAN announce the first commercial success of their collaboration for the automation and efficiency of microbiology laboratories

Download

March 17, 2016

bioMérieux - Release of Registration Document including Annual Financial Report 2015

Download

March 02, 2016

FY 2015 Results - March 2, 2016

Download

March 01, 2016

bioMérieux – 2015 Financial Results

Download

February 24, 2016

BioFire Receives FDA Clearance for FilmArray® Torch with FilmArray® Respiratory Panel and Submits Special 510(k) Applications for Use with additional FilmArray® Panels

Download

January 25, 2016

BioFire’s FilmArray® Meningitis/Encephalitis Panel gets CE marked

Download

January 20, 2016

bioMérieux – Fourth-Quarter 2015 Business Review

Download

January 13, 2016

December 31, 2015 follow up of the market making agreement

Download

January 11, 2016

BioFire Submits Special 510(k) Application to the FDA for the use of FilmArray® Torch, the New High Throughput FilmArray® System with FilmArray® Respiratory Panel

Download

January 04, 2016

bioMérieux acquires Applied Maths and enhances its bioinformatics capabilities with cutting-edge expertise and solutions for the smart use of complex biological data

Download

No regulated information available

2015

October 21, 2015

Business review for the nine months ended September 30, 2015

Download

September 03, 2015

Interim Financial Report 2015

Download

April 24, 2015

bioMérieux Document de référence et rapport financier annuel 2014

Download

April 22, 2015

bioMérieux - First-Quarter 2015 Business Review

Download

No regulated information available

December 04, 2015

November 2015 - Declaration about number of shares issued and number of voting rights

Download

November 05, 2015

October 2015 - Declaration about number of shares issued and number of voting rights

Download

October 08, 2015

September 2015 - Declaration about number of shares issued and number of voting rights

Download

September 04, 2015

August 2015 - Declaration about number of shares issued and number of voting rights

Download

August 07, 2015

July 2015 - Declaration about number of shares issued and number of voting rights

Download

July 06, 2015

June 2015 - Declaration about number of shares issued and number of voting rights

Download

June 04, 2015

May 2015 - Declaration about number of shares issued and number of voting rights

Download

May 07, 2015

April 2015 - Declaration about number of shares issued and number of voting rights

Download

April 03, 2015

March 2015 - Declaration about number of shares issued and number of voting rights

Download

March 06, 2015

February 2015 - Declaration about number of shares issued and number of voting rights

Download

February 05, 2015

January 2015 - Declaration about number of shares issued and number of voting rights

Download

January 07, 2015

December 2014 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

December 14, 2015

bioMérieux and Illumina announce the launch of bioMérieux EpiSeq™, a revolutionary Next-Generation Sequencing service for epidemiological monitoring of bacterial infections

Download

November 03, 2015

bioMérieux introduces GENE-UP®, a new molecular diagnostic solution for food pathogen detection jointly developed with BioFire

Download

October 21, 2015

bioMérieux – Business review for the nine months ended September 30, 2015

Download

October 12, 2015

BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray® Meningitis/Encephalitis panel continuing its extremely favorable business momentum

Download

September 24, 2015

BioFire Defense, a bioMérieux company, receives Emergency Use Assessment and Listing for FilmArray® Ebola Test by the World Health Organization

Download

August 28, 2015

bioMérieux – First-Half 2015 Results

Download

August 21, 2015

Modalités de mise à disposition du rapport financier semestriel 2015

Download

July 27, 2015

bioMérieux receives FDA 510(k) clearance for VIDAS® 3, the new generation of VIDAS®

Download

July 16, 2015

bioMérieux – First-Half 2015 Results

Download

July 15, 2015

June 30, 2015 follow up of the market making agreement

Download

June 19, 2015

Global experts engage in the fight against antimicrobial resistance during the World HAI/Resistance Forum organized by bioMérieux

Download

April 27, 2015

(bioMérieux Communiqué de mise à disposition du document de référence incluant le rapport financier annuel 2014)

Download

April 22, 2015

bioMérieux - First-Quarter 2015 Business Review

Download

April 13, 2015

BioFire Submits De Novo Application to FDA for FilmArray® Meningitis/Encephalitis Panel

Download

March 10, 2015

2014 Financial Results

Download

February 25, 2015

BioFire Receives FDA Clearance for the FilmArray® 2.0 System

Download

February 04, 2015

BioFire Defense, a bioMérieux Company, Receives Prestigious Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola Test

Download

January 21, 2015

bioMérieux and Astute Medical sign a global agreement to develop and market NephroCheck® Test for VIDAS®, an assay to assess the risk of developing acute kidney injury

Download

January 21, 2015

Business Review for the Three Months and Full Year Ended December 31, 2014

Download

January 15, 2015

December 31, 2014 follow up of the market making agreement

Download

January 08, 2015

Strategic alliance between bioMérieux and COPAN to automate clinical microbiology laboratories and enhance their operational efficiency

Download

No regulated information available

2014

September 09, 2014

Interim Financial Report six months ended June 30, 2014

Download

May 05, 2014

bioMérieux Rapport du Président 2013

Download

May 07, 2014

bioMérieux Honoraires des commissaires aux comptes 2013

Download

December 05, 2014

November 2014 - Declaration about number of shares issued and number of voting rights

Download

November 06, 2014

October 2014 - Declaration about number of shares issued and number of voting rights

Download

October 06, 2014

September 2014 - Declaration about number of shares issued and number of voting rights

Download

September 03, 2014

August 2014 - Declaration about number of shares issued and number of voting rights

Download

August 25, 2014

July 2014 - Declaration about number of shares issued and number of voting rights

Download

July 04, 2014

June 2014 - Declaration about number of shares issued and number of voting rights

Download

June 05, 2014

May 2014 - Declaration about number of shares issued and number of voting rights

Download

May 07, 2014

April 2014 - Declaration about number of shares issued and number of voting rights

Download

April 04, 2014

March 2014 - Declaration about number of shares issued and number of voting rights

Download

March 07, 2014

February 2014 – declaration about number of shares issued and number of voting rights

Download

February 06, 2014

January 2014 - Declaration about number of shares issued and number of voting rights

Download

January 07, 2014

December 2013 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

November 17, 2014

bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections

Download

October 26, 2014

BioFire Defense, a bioMérieux company, receives fast-track authorization of FilmArray® Ebola Test

Download

October 21, 2014

Business Review for the Nine Months Ended September 30, 2014

Download

October 09, 2014

bioMérieux inaugurates a new multidisciplinary R&D center for infectious disease diagnostics

Download

September 17, 2014

bioMérieux launches chromID® Salmonella Elite, the new generation of culture media for earlier detection of Salmonella strains in clinical fecal samples

Download

September 02, 2014

bioMérieux - First-Half 2014 Results

Download

July 21, 2014

bioMérieux VIRTUO™, the new generation of blood culture system, is CE-marked

Download

July 16, 2014

bioMérieux - Second-Quarter 2014 Business Review

Download

July 03, 2014

June 30, 2014 follow up of the market making agreement

Download

May 28, 2014

The General Shareholders’ Meeting of bioMérieux approves the appointment of two new independent directors

Download

May 03, 2014

BioFire’s FilmArray® Gastrointestinal Panel Receives FDA Clearance

Download

April 30, 2014

bioMérieux Communiqué de mise à disposition du document de référence incluant le rapport financier annuel 2013

Download

April 24, 2014

P 0745 ECCMID 2014JM ROCHE chromID Salmonella ELITE VF

Download

April 22, 2014

First-Quarter 2014 Business Review

Download

April 15, 2014

Alexandre Mérieux Assumes Role of bioMérieux CEO

Download

March 18, 2014

bioMérieux - 2013 Financial Results

Download

February 25, 2014

bioMérieux strengthens its Clostridium difficile offer with the launch of VIDAS® C. difficile GDH

Download

February 19, 2014

BioFire Submits 510(k) Application to FDA for FilmArray® Gastrointestinal Panel

Download

January 24, 2014

Appointment of Claire Giraut as bioMérieux’s Corporate Vice President & Chief Financial Officer

Download

January 21, 2014

Business Review for the year ended December 31, 2013

Download

January 16, 2014

bioMérieux finalizes acquisition of the U.S. company BioFire, specialized in molecular biology

Download

January 09, 2014

December 31, 2013 followup of the market making agreement

Download

No regulated information available

2013

September 13, 2013

Interim Financial Report six months ended June 30, 2013

Download

April 12, 2013

Rapport Financier annuel 2012

Download

May 06, 2013

Report of the Chairman of the Board of Directors on Corporate Governance and Internal control report

Download

April 22, 2013

Avis de mise à disposition du Rapport du Président du Conseil d'administration sur le contrôle interne

Download

March 26, 2013

Honoraires des Commissaires aux Comptes 2012

Download

December 05, 2013

November 2013 - Declaration about number of shares issued and number of voting rights

Download

November 06, 2013

October 2013 - Declaration about number of shares issued and number of voting rights

Download

October 04, 2013

September 2013 - Declaration about number of shares issued and number of voting rights

Download

September 04, 2013

August 2013 - Declaration about number of shares issued and number of voting rights

Download

August 20, 2013

July 2013 - Declaration about number of shares issued and number of voting rights

Download

July 04, 2013

June 2013 - Declaration about number of shares issued and number of voting rights

Download

June 10, 2013

May 2013 - Declaration about number of shares issued and number of voting rights

Download

April 05, 2013

March 2013 - Declaration about number of shares issued and number of voting rights

Download

March 05, 2013

February 2013 - Declaration about number of shares issued and number of voting rights

Download

February 06, 2013

January 2013 - Declaration about number of shares issued and number of voting rights

Download

January 07, 2013

December 2012 - Declaration about number of shares issued and number of voting rights

Download

October 10, 2013

Communiqué de mise à disposition du Prospectus Emission Obligataire visé par l'AMF Octobre 2013

Download

December 04, 2013

bioMérieux is Moving Forward to a New Molecular Biology Workflow Solution for Reference or Centralized Laboratories

Download

November 27, 2013

bioMérieux Announces Termination of its Collaboration with Biocartis in Molecular Biology

Download

October 28, 2013

bioMérieux launches the Parvovirus B19 R-gene® kit, a new ARGENE® test for the detection and quantification of the three Parvovirus B19 genotypes

Download

October 22, 2013

Business Review for the Nine Months Ended September 30, 2013

Download

October 08, 2013

Successful placement of Inaugural €300-Million Issue of 7-Year Bonds

Download

September 27, 2013

bioMérieux launches a new assay for vitamin D testing: VIDAS® 25 OH Vitamin D Total

Download

September 03, 2013

Avis de mise à disposition du rapport financier semestriel relatif au semestre clos le 30 juin 2013

Download

September 03, 2013

bioMérieux makes a significant acquisition in molecular biology in the U.S.

Download

September 03, 2013

First-Half 2013 Results

Download

August 21, 2013

DRAFT Press Release

Download

August 21, 2013

bioMérieux Announces U.S. FDA Clearance for VITEK® MS, a Revolutionary Technology which Reduces Microbial Identification from Days to Minutes Reinforcing Medical Value of Diagnostics

Download

July 17, 2013

First-Half 2013 Business Review

Download

July 04, 2013

Bilan semestriel du contrat de liquidité

Download

June 27, 2013

International Experts Join Forces against Superbugs at the 4th World Forum on Healthcare-Associated Infections and Antimicrobial Resistance

Download

June 19, 2013

bioMérieux receives CE marking for VIDAS® 3, the new generation of VIDAS®

Download

May 30, 2013

bioMérieux Receives FDA Approval for THxIDTM-BRAF Companion Diagnostic Test

Download

May 30, 2013

bioMérieux annonces the launch of TEMPO EB, première solution automatisée pour le dénombrement des Entérobactéries en 24h

Download

May 21, 2013

Communiqué de mise à disposition du document de référence 2012

Download

May 21, 2013

Nicolas Cartier appointed Corporate Vice President, Industrial Microbiology Unit of bioMérieux

Download

April 22, 2013

bioMérieux - First-Quarter 2013 Business Review

Download

April 11, 2013

Avis de mise à disposition du rapport financier annuel 2012

Download

March 25, 2013

Veolia Environnement and bioMérieux initiate a research partnership to develop an innovative monitoring system for drinking water quality

Download

March 12, 2013

bioMérieux - 2012 Financial Results

Download

January 22, 2013

2012 Business Review & Investor Day

Download

January 04, 2013

December 31, 2012 followup of the market making agreement

Download

No regulated information available

2012

September 04, 2012

Rapport financier semestriel relatif au premier semestre clos le 30 juin 2012

Download

July 19, 2012

bioMérieux - First-Half 2012 Business Review

Download

May 29, 2012

Doc de Ref 2011_eng_V2

Download

April 24, 2012

bioMérieux - First-Quarter 2012 Business Review

Download

January 24, 2012

bioMérieux – 2011 Business Review

Download

April 27, 2011

Annual Report 2010

Download

No regulated information available

December 07, 2012

Declaration about number of shares issued and number of voting rights

Download

November 07, 2012

October 2012 - Declaration about number of shares issued and number of voting rights

Download

October 04, 2012

September 2012 - Declaration about number of shares issued and number of voting rights

Download

September 05, 2012

August 2012 - Declaration about number of shares issued and number of voting rights

Download

August 03, 2012

July 2012 - Declaration about number of shares issued and number of voting rights

Download

July 05, 2012

June 2012 - Declaration about number of shares issued and number of voting rights

Download

June 05, 2012

May 2012 - Declaration about number of shares issued and number of voting rights

Download

May 07, 2012

April 2012 - Declaration about number of shares issued and number of voting rights

Download

April 05, 2012

March 2012 - Declaration about number of shares issued and number of voting rights

Download

March 06, 2012

February 2012 - Declaration about number of shares issued and number of voting rights

Download

February 03, 2012

January 2012 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

December 04, 2012

bioMérieux Opens a Subsidiary in Vietnam, Strengthening its Footprint in High-growth Southeast Asia

Download

December 04, 2012

bioMérieux launches a new VIDAS® EBV test for the diagnosis of infectious mononucleosis

Download

November 14, 2012

bioMérieux and Quanterix Sign Strategic Partnership in Ultrasensitive and Multiplex Immunoassays

Download

November 06, 2012

VIDAS® 3, the New-generation VIDAS®

Download

October 31, 2012

Dr. Mark Miller joins bioMérieux as Chief Medical Officer

Download

October 23, 2012

bioMérieux - Business Review for the nine months ended September 30, 2012

Download

October 09, 2012

Avis de projet de fusion bioMérieux / AES Laboratoire groupe

Download

October 01, 2012

Thermo Fisher Scientific and bioMérieux Renew Partnership for Improved Detection of Sepsis Using PCT Biomarker

Download

September 24, 2012

Avis de projet de fusion bioMérieux - ARGENE

Download

September 04, 2012

bioMérieux - First-Half Results at June 30, 2012

Download

July 19, 2012

bioMérieux - First-Half 2012 Business Review

Download

May 03, 2012

bioMérieux Completes its VIDAS® Hepatitis Panel with a New Test for the Diagnosis of Hepatitis C

Download

April 24, 2012

bioMérieux - First-Quarter 2012 Business Review

Download

April 11, 2012

bioMérieux’s Myla® Named as Finalist in the 2012 Medical Design Excellence Awards

Download

March 27, 2012

Detection of Schmallenberg virus made possible by bioMérieux: the ADIAGENE PCR kit has been validated by ANSES

Download

March 13, 2012

bioMérieux - 2011 Financial Results

Download

January 24, 2012

bioMérieux - 2011 Business Review

Download

No regulated information available

2010

October 21, 2010

Business Review for the nine months ended September 30, 2010

Download

September 22, 2010

Reference Document and Annual Financial Report 2009

Download

September 22, 2010

Reference Document 2009

Download

September 03, 2010

2010 First-Half Review

Download

July 21, 2010

bioMérieux - First-Half 2010 Business Review

Download

April 20, 2010

bioMérieux - First Quarter 2010 Business Review

Download

January 21, 2010

2009 Business Review

Download

April 30, 2010

Rapport sur le gouvernement d'entreprise et le contrôle interne 2009

Download

April 28, 2010

Honoraires des Commissaires aux Comptes 2009 et 2008

Download

November 30, 2010

November 2010 - Declaration about number of shares issued and number of voting rights

Download

November 04, 2010

October 2010 - Declaration about number of shares issued and number of voting rights

Download

October 04, 2010

September 2010 - Declaration about number of shares issued and number of voting rights

Download

September 02, 2010

August 2010 - Declaration about number of shares issued and number of voting rights

Download

July 23, 2010

July 2010 - Declaration about number of shares issued and number of voting rights

Download

June 28, 2010

June 2010 - Declaration about number of shares issued and number of voting rights

Download

May 26, 2010

May 2010 - Declaration about number of shares issued and number of voting rights

Download

April 27, 2010

April 2010 - Declaration about number of shares issued and number of voting rights

Download

March 26, 2010

March 2010 - Declaration about number of shares issued and number of voting rights

Download

February 25, 2010

February 2010 - Declaration about number of shares issued and number of voting rights

Download

January 27, 2010

January 2010 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

January 19, 2011

Microsoft Word - PR bioMerieux Q4 Sales 2010 EN.doc

Download

December 01, 2010

bioMérieux Restructures its Clinical Culture Media Business in North America and Announces the Closing of its Portland, OR Plant

Download

November 04, 2010

bioMérieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics

Download

October 26, 2010

Alain Mérieux Organizes his Succession at the Head of bioMérieux, Entrusting Jean-Luc Bélingard with the Role of Président Directeur Général

Download

October 21, 2010

bioMérieux - Business Review for the nine months ended September 30, 2010

Download

September 06, 2010

Avis de mise à disposition du rapport financier semestriel relatif au premier semestre clos le 30 juin 2010

Download

September 03, 2010

2010 First-Half Review

Download

July 29, 2010

Hyglos Honored with 2010 Food Safety Innovation Award for Technology Used in bioMérieux’s VIDAS® UP E. coli O157 (including H7)

Download

July 29, 2010

Microsoft Word - IAFP FS Innovation Award PR 20100729.doc

Download

July 21, 2010

bioMérieux - First-Half 2010 Business Review

Download

June 05, 2010

Microsoft Word - bioTheranostics 2010 ASCO announcement Final 4 June.doc

Download

May 24, 2010

bioMérieux Showcases Myla™ at ASM 2010: New Informatics Solution to Transform the Microbiology Laboratory

Download

May 20, 2010

Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Microbiology

Download

May 17, 2010

bioMérieux Strengthens North American Executive Management Team

Download

May 16, 2010

bioMérieux Co-sponsors French Medical Days in Shanghai

Download

May 07, 2010

bioMérieux and GlaxoSmithKline Enter into Alliance to Develop Molecular Theranostic Test for Cancer Treatment Selection

Download

May 06, 2010

List of 2009 press releases and corporate communications

Download

April 28, 2010

Communiqué de mise à disposition du document de référence incluant le rapport financier annuel au 31 décembre 2009

Download

April 20, 2010

bioMérieux - First Quarter 2010 Business Review

Download

April 20, 2010

PR bioM\351rieux Q1 Sales 2010 EN

Download

March 05, 2010

bioMérieux 2015

Download

March 05, 2010

bioMérieux results 2009

Download

January 21, 2010

bioMérieux - 2009 Business Review

Download

January 15, 2010

December 31, 2009 - Half-yearly follow-up of the market making agreement

Download

No regulated information available

2009

October 22, 2009

Reference Document 2008

Download

October 19, 2009

bioMérieux - Business Review for the nine months ended September 30, 2009

Download

September 04, 2009

RAPPORT FINANCIER SEMESTRIEL RELATIF AU PREMIER SEMESTRE CLOS LE 30 JUIN 2009

Download

July 23, 2009

bioMérieux - First-Half 2009 Business Review

Download

April 24, 2009

Rapport financier annuel au 31 décembre 2008

Download

April 22, 2009

First-Quarter 2009 Business Review: Sales Growth in Line with Objectives

Download

January 19, 2009

bioMérieux - 2008 Business Review

Download

October 22, 2009

Prospectus 2008

Download

October 22, 2009

Prospectus 2008

Download

December 18, 2009

December 2009 - Declaration about number of shares issued and number of voting rights

Download

November 26, 2009

November 2009 - Declaration about number of shares issued and number of voting rights

Download

October 29, 2009

October 2009 - Declaration about number of shares issued and number of voting rights

Download

September 30, 2009

September 2009 - Declaration about number of shares issued and number of voting rights

Download

August 26, 2009

August 2009 - Declaration about number of shares issued and number of voting rights

Download

July 16, 2009

July 2009 - Declaration about number of shares issued and number of voting rights

Download

July 16, 2009

June 2009 - Declaration about number of shares issued and number of voting rights

Download

May 20, 2009

May 2009 - Declaration about number of shares issued and number of voting rights

Download

April 28, 2009

April 2009 - Declaration about number of shares issued and number of voting rights

Download

February 27, 2009

February 2009 - Declaration about number of shares issued and number of voting rights

Download

January 29, 2009

January 2009 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

November 20, 2009

Avis de mise à disposition des documents préparatoires à l'Assemblée générale du 11 juin 2009

Download

October 19, 2009

bioMérieux - Business Review for the nine months ended September 30, 2009

Download

September 04, 2009

First-Half 2009 Results

Download

September 04, 2009

Avis de mise à disposition du rapport financier semestriel relatif au premier semestre clos le 30 juin 2009

Download

July 23, 2009

bioMérieux - First-Half 2009 Business Review

Download

July 07, 2009

June 30, 2009 - Half-yearly follow-up of the market making agreement

Download

June 11, 2009

Communiqué de mise à disposition du document de référence au 31 décembre 2008

Download

June 10, 2009

Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2008

Download

May 19, 2009

List of 2008 press releases and corporate communications

Download

May 18, 2009

Microsoft Word - PR bioMérieux HIV-1 v2.0 20090519.doc

Download

May 12, 2009

2009 ESCMID/bioMérieux Research Grant in Clinical Microbiology

Download

April 22, 2009

First-Quarter 2009 Business Review: Sales Growth in Line with Objectives

Download

April 22, 2009

bioMérieux - First-Quarter 2009 Business Review

Download

January 19, 2009

bioMérieux - 2008 Business Review

Download

January 09, 2009

31 December 2008 - Half-yearly follow-up of the market making agreement

Download

No regulated information available

2008

November 05, 2008

Reference Document 2007

Download

October 27, 2008

bioMérieux - Business Review for the nine months ended September 30, 2008

Download

July 22, 2008

bioMérieux - First-Half 2008 Business Review

Download

April 30, 2008

Rapport financier annuel au 31 décembre 2007

Download

April 28, 2008

bioMérieux - First Quarter 2008 Business Review

Download

January 21, 2008

bioMérieux - 2007 Business Review

Download

No regulated information available

December 23, 2008

December 2008 - Declaration about number of shares issued and number of voting rights

Download

October 28, 2008

October 2008 - Declaration about number of shares issued and number of voting rights

Download

July 18, 2008

July 2008 - Declaration about number of shares issued and number of voting rights

Download

June 30, 2008

June 2008 - Declaration about number of shares issued and number of voting rights

Download

April 24, 2008

April 2008 - Declaration about number of shares issued and number of voting rights

Download

March 31, 2008

March 2008 - Declaration about number of shares issued and number of voting rights

Download

February 22, 2008

February 2008 - Declaration about number of shares issued and number of voting rights

Download

January 30, 2008

January 2008 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

December 22, 2008

Recommendations AFEP - MEDEF

Download

October 27, 2008

bioMérieux Business review for the nine months ended September 30, 2008

Download

September 24, 2008

bioMérieux to Develop New Highly-Specific, Non-invasive Test for Prostate Cancer, Reducing Unnecessary Biopsies

Download

September 10, 2008

bioMérieux Gains Critical Oncology and Theranostics Capabilities with the Acquisition of Molecular Diagnostics Company AviaraDx

Download

September 05, 2008

First-Half 2008 Financial Report Sustained sales growth while consolidating profitability - Operating income before non-recurring items up 7.6%

Download

July 22, 2008

bioMérieux - First-Half 2008 Review

Download

July 09, 2008

30 June 2008 - Half-yearly follow-up of the market making agreement

Download

June 30, 2008

Votes of resolutions - Results - Shareholders's meeting - June 12, 2008

Download

May 19, 2008

List of 2007 press releases and corporate communications

Download

April 28, 2008

bioMérieux - First Quarter 2008 Business Review

Download

April 15, 2008

bioMérieux Bestowed 2007 Frost & Sullivan European Healthcare-Associated Infection Control Technology Leadership Award

Download

March 14, 2008

2007 Financial Results

Download

January 21, 2008

2007 Business Review - 2007: sales up 7.4% like-for-like

Download

No regulated information available

2007

October 25, 2007

bioMérieux - Business Review for the nine months ended September 30, 2007

Download

July 26, 2007

bioMérieux - First-Half 2007 Business Review

Download

April 20, 2007

bioMérieux - First-Quarter 2007 Business Review

Download

No regulated information available

December 21, 2007

December 2007 - Declaration about number of shares issued and number of voting rights

Download

November 26, 2007

November 2007 - Declaration about number of shares issued and number of voting rights

Download

October 26, 2007

October 2007 - Declaration about number of shares issued and number of voting rights

Download

September 27, 2007

September 2007 - Declaration about number of shares issued and number of voting rights

Download

July 17, 2007

July 2007 - Declaration about number of shares issued and number of voting rights

Download

June 27, 2007

June 2007 - Declaration about number of shares issued and number of voting rights

Download

May 30, 2007

May 2007 - Declaration about number of shares issued and number of voting rights

Download

April 30, 2007

April 2007 - Declaration about number of shares issued and number of voting rights

Download

March 27, 2007

March 2007 - Declaration about number of shares issued and number of voting rights

Download

February 28, 2007

February 2007 - Declaration about number of shares issued and number of voting rights

Download

January 31, 2007

January 2007 - Declaration about number of shares issued and number of voting rights

Download

No regulated information available

May 16, 2007

Microsoft Word - Liste des publications de communiqu.s de presse et corpora.

Download

January 30, 2007

Microsoft Word - Bilan semestriel 2006-12-31.doc

Download

No regulated information available

2006

No regulated information available

June 06, 2006

Microsoft Word - Declaration_Transactions_2006-06-05.doc

Download

May 19, 2006

List of 2005 publications

Download

No regulated information available

2005

No regulated information available

January 19, 2012

Date , Marcy l’Etoile : bioMérieux announces the launch of two new tests for use on its VIDAS immunoanalysis system

Download

October 19, 2005

Microsoft Word - bioMerieux_Sales_2005_Q3_Final.DOC

Download

October 12, 2005

05_EXT_06 Biomerieux final.doc

Download

September 23, 2005

Microsoft Word - PR_bioMerieux_2005H1 Results_GB.doc

Download

July 19, 2005

Microsoft Word - bMx 2005 Q2 Sales_final.doc

Download

April 19, 2005

q1_sales_final.pdf

Download

March 18, 2005

deH

Download

March 10, 2005

CP - Approved statement of press release by CAMS.doc

Download

March 01, 2005

CP BRAHMS GB FINAL.doc

Download

January 18, 2005

1

Download

January 05, 2005

CP - VITEK 2 COMPACT - FINAL - GB.doc

Download

October 19, 2004

Sales Q3_Final.doc

Download

September 30, 2004

CP_2004H1_Final_English.doc

Download

No regulated information available

2004

No regulated information available

April 30, 2004

Document de Base

Download

January 19, 2012

biomerieux_gen_probe_oct_7_04__2_.pdf

Download

December 15, 2004

CP Applied-bMx-nov2004-GB-v4.doc

Download

October 07, 2004

CP-BMX-GP-4-FR.doc

Download

February 13, 2004

Web Contents Press Kit.doc

Download

No regulated information available

2003

No regulated information available

2002

No regulated information available

2001

No regulated information available

2000

No regulated information available

1999

No regulated information available

1998

No regulated information available

2025

No regulated information available

March 04, 2025

February 2025 - Declaration about number of shares issued and number of voting rights

Download

February 06, 2025

January 2025 - Declaration about number of shares issued and number of voting rights

Download

March 06, 2025

2024 Financial Results - Press Release

Download

February 12, 2025

GENE-UP® Typer - Press Release

Download

January 31, 2025

BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid FDA Clearance - Press Release

Download

January 12, 2025

bioMérieux at the 43rd JP Morgan Healthcare Conference - Press Release

Download

January 12, 2025

SpinChip Acquisition - Press Release

Download

No regulated information available

Regulated Information

Search by Year

2024

Prospectus referring to Public offering

Fees received by Statutory auditors

Annual, biannual and quaterly information

Total number of voting rights and shares

Press Releases

General meeting preparatory documents

Information published pursuant to article 223-21 of the AMF regulation

Shares repurchase

Financial security, Law report of the Chairman of the Board on Corporate governance and internal contral

2023

Annual, biannual and quaterly information

Financial security, Law report of the chairman of the Board on Corporate governance and internal control report

Fees received by Statutory auditors

Total number of voting rights and shares

Prospectus referring to Public offering

Press Releases

General meeting preparatory documents

Shares repurchase

Information published pursuant to article 223-21 of the AMF regulation

2022

Annual, biannual and quaterly information

Financial security, Law report of the chairman of the Board on Corporate governance and internal control report

Fees received by Statutory auditors

Total number of voting rights and shares

Prospectus referring to Public offering

Releases

General meeting preparatory documents

Share repurchase